Details

Autor(en) / Beteiligte

• Gyurkocza, Boglarka
• Nath, Rajneesh
• Seropian, Stuart E.
• Choe, Hannah
• Litzow, Mark R.
• Koshy, Nebu
• Stiff, Patrick
• Abboud, Camille
• Tomlinson, Benjamin
• Abhyankar, Sunil
• Hari, Parameswaran
• Chen, George L
• Al-Kadhimi, Zaid
• Sabloff, Mitchell
• Orozco, Johnnie J.
• Foran, James
• Kebriaei, Partow
• Jamieson, Katarzyna
• Magalhaes-Silverman, Margarida
• van Besien, Koen
• Schuster, Michael W
• Law, Arjun Datt
• Levy, Moshe Yair
• Lazarus, Hillard M.
• Giralt, Sergio A
• Berger, Mark S.
• Spross, Jennifer
• Desai, Avinash
• Reddy, Vijay
• Pagel, John M.

Titel

40 - High Rates of Transplantation in the Phase III Sierra Trial Utilizing Anti-CD45 (Iodine) 131I-Apamistamab (Iomab-B) Conditioning with Successful Engraftment and Tolerability in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) Patients after Lack of Response to Conventional Care and Targeted Therapies

Ist Teil von

• Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S35-S36

Ort / Verlag

Elsevier Inc

Erscheinungsjahr

2022

Quelle

Alma/SFX Local Collection